Before revision: Phase III trials were published in January 2023 on CVO+ resulted in a significantly higher rate of treatment successEfficacy and safety of CVO PLUS CURATIF capsules, Malagasy improved traditional medication for treating COVID-19 a randomized double blind placebo controlled trials.
After revision: Phase III trials were published in January 2023 on CVO+ resulted in a significantly higher rate of treatment